NOV
43
4
CSCO
58
4
OXY
41
3
SRE
45
3
NEM
48
-2
BA
40
-2
AIG
51
-3
ZTS
31
-2
RRC
46
3
FFIV
52
3
UNP
40
-3
DAL
72
2
PH
62
2
PNC
59
2
CHD
34
3
NAVI
41
-6
SNA
72
19
CMS
50
2
RCL
69
3
FOX
64
4
NOV
43
4
CSCO
58
4
OXY
41
3
SRE
45
3
NEM
48
-2
BA
40
-2
AIG
51
-3
ZTS
31
-2
RRC
46
3
FFIV
52
3
UNP
40
-3
DAL
72
2
PH
62
2
PNC
59
2
CHD
34
3
NAVI
41
-6
SNA
72
19
CMS
50
2
RCL
69
3
FOX
64
4
Financhill
Back

UroGen Pharma Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

URGN
UroGen Pharma

Last Price:
$15.12
Seasonality Move:
0.45%

7 Day Trial

ALL ACCESS PASS

$ 7

UroGen Pharma Stock Forecast

  • Over the next 52 weeks, UroGen Pharma has on average historically risen by 9.1% based on the past 8 years of stock performance.
  • UroGen Pharma has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%
  • Is UroGen Pharma Stock Undervalued?
    The current UroGen Pharma [URGN] share price is $15.41. The Score for URGN is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • URGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will UroGen Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, UroGen Pharma has on average historically risen by 9.1% based on the past 8 years of stock performance.

UroGen Pharma Stock Rating

Buy
62
UroGen Pharma (URGN) is a Buy

Is UroGen Pharma overpriced?

  • UroGen Pharma has risen higher in 3 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 37.5%

UroGen Pharma Stock Price History

Is URGN stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
urogen.com

52-Week Data

52-Week High:
17.00
52-Week Low:
3.42

Prediction Charts

Market Cap:
710.5M
Price in USD:
15.41
Volume:
2M
Beta:
1.31

Technical Analysis

SMA50:
10.24
SMA100:
10.41
SMA200:
11.00
52-Wk Change:
-8.76%

Stock Predictions

  • Is UroGen Pharma stock public?
    Yes, UroGen Pharma is a publicly traded company.
  • What is the UroGen Pharma stock quote today?
    The UroGen Pharma stock price is 15.41 USD today.
  • How to buy UroGen Pharma stock online?
    You can buy UroGen Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-27 13.23 13.49 13.85 13.00
Jun-30 13.81 13.70 13.93 13.47
Jul-1 13.76 13.02 13.81 12.95
Jul-2 12.88 12.96 13.64 12.73
Jul-3 12.92 13.58 13.62 12.89
Jul-7 13.48 13.49 13.94 13.35
Jul-8 13.60 13.71 13.89 13.26
Jul-9 13.84 13.81 14.31 13.57
Jul-10 13.74 14.64 14.66 13.55
Jul-11 14.41 14.24 14.64 13.91
Jul-14 14.15 14.49 15.24 14.09
Jul-15 14.55 14.04 14.61 13.79
Jul-16 14.30 14.34 14.49 14.00
Jul-17 14.33 15.41 15.50 14.33

UroGen Pharma Earnings

UroGen Pharma Earnings Report: Per Share UroGen Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

UroGen Pharma Forecast Revenue Growth

UroGen Pharma Stock Analysis: Historical quarterly revenues per share for UroGen Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.22 per share, an increase this year of $0.25 per share, and an increase next year of $1.85 per share.

* UroGen Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.